Sabra Health Care REIT Q4 2021 Earnings Report
Key Takeaways
Sabra Health Care REIT reported a net loss of $(0.11) per diluted common share for Q4 2021. Normalized FFO was $0.39 and AFFO was $0.20. The company completed the sale of eight facilities for gross proceeds of $85.9 million and continued to maintain a strong Net Debt to Adjusted EBITDA ratio of 4.98x.
Net Loss per share was $(0.11) for Q4 2021.
FFO was $0.11, Normalized FFO was $0.39, and AFFO was $0.20.
EBITDARM Coverage for skilled nursing and specialty hospital portfolios were 1.77x and 3.83x, respectively.
The company completed the sale of four skilled nursing/transitional care facilities, two senior housing communities and two hospitals for gross sales proceeds of $85.9 million.
Sabra Health Care REIT
Sabra Health Care REIT
Forward Guidance
Sabra is optimistic that absent the emergence of a new variant, their portfolio and the broader industry can get back on track toward recovery. The company is also pleased to have agreed with Avamere on a restructuring of their lease obligations and believe the restructured lease provides them with a path for success. Their pending Canadian joint venture gets 2022 off to a good start on the investment front. Canada has proven to be a stable market and they look forward to continued growth there.
Positive Outlook
- COVID cases in our portfolio peaked before the end of January and then started dropping, materially so for the staff at our facilities.
- With more staff available, occupancy has increased the first two weeks of February.
- We are more optimistic that absent the emergence of a new variant, our portfolio and the broader industry can get back on track toward recovery.
- We are also pleased to have agreed with Avamere on a restructuring of their lease obligations and believe the restructured lease provides them with a path for success.
- Our pending Canadian joint venture gets 2022 off to a good start on the investment front.